Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump

Growth was broad-based across segments

Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials

Strengthening India’s pharma brand through compliance-first manufacturing: Vijay Kumar Aggarwal, MD, Medicef Pharma

By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage

Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform

NIFTY Pharma shows stable trend amid cautious market sentiment

Muted movement reflects consolidation phase as investors await earnings triggers

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%

Anlon Healthcare gets Brickwork rating withdrawal after facility closure

This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities

Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit

The license is valid for five years, effective from April 9, 2026